Metal binding to the amyloid-β peptides in the presence of biomembranes: potential mechanisms of cell toxicity

[1]  S. Ebbinghaus,et al.  Effects of in vivo conditions on amyloid aggregation. , 2019, Chemical Society reviews.

[2]  F. Sobott,et al.  Native Ion Mobility-Mass Spectrometry reveals the formation of β-barrel shaped Amyloid-β hexamers in a membrane-mimicking environment. , 2019, Journal of the American Chemical Society.

[3]  A. Gräslund,et al.  Membrane-mimetic systems for biophysical studies of the amyloid-β peptide. , 2019, Biochimica et biophysica acta. Proteins and proteomics.

[4]  A. Gräslund,et al.  Copper ions induce dityrosine-linked dimers in human but not in murine islet amyloid polypeptide (IAPP/amylin). , 2019, Biochemical and biophysical research communications.

[5]  R. Lathe,et al.  The antimicrobial protection hypothesis of Alzheimer's disease , 2018, Alzheimer's & Dementia.

[6]  D. Otzen,et al.  Early events in copper‐ion catalyzed oxidation of &agr;‐synuclein , 2018, Free radical biology & medicine.

[7]  Dennis M. Krüger,et al.  Amyloid-β Peptide Interactions with Amphiphilic Surfactants: Electrostatic and Hydrophobic Effects. , 2018, ACS chemical neuroscience.

[8]  C. Bobo,et al.  Interaction of Aβ1-42 peptide or their variant with model membrane of different composition probed by infrared nanospectroscopy. , 2018, Nanoscale.

[9]  L. Ilag,et al.  Alzheimer’s disease and cigarette smoke components: effects of nicotine, PAHs, and Cd(II), Cr(III), Pb(II), Pb(IV) ions on amyloid-β peptide aggregation , 2017, Scientific Reports.

[10]  M. Tomás,et al.  Oxidative stress and the amyloid beta peptide in Alzheimer’s disease , 2017, Redox biology.

[11]  Johan Björkeroth,et al.  Lipid membranes catalyse the fibril formation of the amyloid-β (1-42) peptide through lipid-fibril interactions that reinforce secondary pathways. , 2017, Biochimica et biophysica acta. Biomembranes.

[12]  M. Rheinstädter,et al.  Membrane-Accelerated Amyloid-β Aggregation and Formation of Cross-β Sheets , 2017, Membranes.

[13]  Shina Caroline Lynn Kamerlin,et al.  Micelle Maker: An Online Tool for Generating Equilibrated Micelles as Direct Input for Molecular Dynamics Simulations , 2017, ACS omega.

[14]  A. Gräslund,et al.  The Amyloid-beta Peptide in Amyloid Formation Processes : Interactions with Blood Proteins and Naturally Occurring Metal Ions , 2017 .

[15]  C. Dobson,et al.  Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. , 2017, Annual review of biochemistry.

[16]  Eugenia Trushina,et al.  Oxidative Stress, Synaptic Dysfunction, and Alzheimer’s Disease , 2017, Journal of Alzheimer's disease : JAD.

[17]  M. G. Savelieff,et al.  Towards an understanding of amyloid-β oligomers: characterization, toxicity mechanisms, and inhibitors. , 2017, Chemical Society reviews.

[18]  Youssra K Al-Hilaly,et al.  The involvement of dityrosine crosslinking in α-synuclein assembly and deposition in Lewy Bodies in Parkinson’s disease , 2016, Scientific Reports.

[19]  J. H. Viles,et al.  Ion Channel Formation by Amyloid-β42 Oligomers but Not Amyloid-β40 in Cellular Membranes* , 2016, The Journal of Biological Chemistry.

[20]  J. Abrahams,et al.  Characterization of Mn(II) ion binding to the amyloid-β peptide in Alzheimer's disease. , 2016, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.

[21]  J. Abrahams,et al.  Specific Binding of Cu(II) Ions to Amyloid-Beta Peptides Bound to Aggregation-Inhibiting Molecules or SDS Micelles Creates Complexes that Generate Radical Oxygen Species. , 2016, Journal of Alzheimer's disease : JAD.

[22]  M. Gairí,et al.  Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments , 2016, Proceedings of the National Academy of Sciences.

[23]  J. Hardy,et al.  The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.

[24]  D. Filippov,et al.  Interaction of the amyloid β peptide with sodium dodecyl sulfate as a membrane-mimicking detergent , 2016, Journal of biological physics.

[25]  Thomas L. Williams,et al.  Stabilization of native amyloid β-protein oligomers by Copper and Hydrogen peroxide Induced Cross-linking of Unmodified Proteins (CHICUP). , 2016, Biochimica et biophysica acta.

[26]  Astrid Gräslund,et al.  Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation , 2015, Proceedings of the National Academy of Sciences.

[27]  Patrick Walsh,et al.  Differences between amyloid-β aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease. , 2014, Chemical Society reviews.

[28]  J. Abrahams,et al.  Endogenous polyamines reduce the toxicity of soluble aβ peptide aggregates associated with Alzheimer's disease. , 2014, Biomacromolecules.

[29]  J. Abrahams,et al.  The hairpin conformation of the amyloid β peptide is an important structural motif along the aggregation pathway , 2014, JBIC Journal of Biological Inorganic Chemistry.

[30]  J. Fantini,et al.  Bexarotene blocks calcium-permeable ion channels formed by neurotoxic Alzheimer's β-amyloid peptides. , 2014, ACS chemical neuroscience.

[31]  Z. Leonenko,et al.  Effect of Metals on Kinetic Pathways of Amyloid-β Aggregation , 2014, Biomolecules.

[32]  Thomas L. Williams,et al.  A central role for dityrosine crosslinking of Amyloid-β in Alzheimer’s disease , 2013, Acta neuropathologica communications.

[33]  R. Cappai,et al.  Synthetic dityrosine-linked β-amyloid dimers form stable, soluble, neurotoxic oligomers , 2013 .

[34]  J. Danielsson,et al.  Biophysical Studies of the Amyloid β‐Peptide: Interactions with Metal Ions and Small Molecules , 2013, Chembiochem : a European journal of chemical biology.

[35]  P. Faller,et al.  Role of metal ions in the self-assembly of the Alzheimer's amyloid-β peptide. , 2013, Inorganic chemistry.

[36]  J. Brender,et al.  Zinc stabilization of prefibrillar oligomers of human islet amyloid polypeptide. , 2013, Chemical communications.

[37]  Z. Leonenko,et al.  Cu2+ Affects Amyloid-β (1–42) Aggregation by Increasing Peptide-Peptide Binding Forces , 2013, PloS one.

[38]  A. Karlström,et al.  Engineered non-fluorescent Affibody molecules facilitate studies of the amyloid-beta (Aβ) peptide in monomeric form: low pH was found to reduce Aβ/Cu(II) binding affinity. , 2013, Journal of inorganic biochemistry.

[39]  Ann Tiiman,et al.  The missing link in the amyloid cascade of Alzheimer’s disease – Metal ions , 2013, Neurochemistry International.

[40]  Anders Olofsson,et al.  Ca(2+) enhances Aβ polymerization rate and fibrillar stability in a dynamic manner. , 2013, The Biochemical journal.

[41]  J. Abrahams,et al.  Cellular polyamines promote amyloid-beta (Aβ) peptide fibrillation and modulate the aggregation pathways. , 2013, ACS chemical neuroscience.

[42]  Ruth Nussinov,et al.  Metal binding sites in amyloid oligomers: Complexes and mechanisms , 2012 .

[43]  Ayyalusamy Ramamoorthy,et al.  Two-step mechanism of membrane disruption by Aβ through membrane fragmentation and pore formation. , 2012, Biophysical journal.

[44]  Jonathan A. Fauerbach,et al.  Biophysical properties and cellular toxicity of covalent crosslinked oligomers of α-synuclein formed by photoinduced side-chain tyrosyl radicals. , 2012, Free radical biology & medicine.

[45]  P. Faller,et al.  Reevaluation of copper(I) affinity for amyloid-β peptides by competition with ferrozine--an unusual copper(I) indicator. , 2012, Chemistry.

[46]  I. Parker,et al.  Single-channel Ca2+ imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology , 2011, The Journal of cell biology.

[47]  M. Suwalsky,et al.  Physiological cholesterol concentration is a neuroprotective factor against β-amyloid and β-amyloid-metal complexes toxicity. , 2011, Journal of inorganic biochemistry.

[48]  P. Faller,et al.  Iron(II) binding to amyloid-β, the Alzheimer's peptide. , 2011, Inorganic chemistry.

[49]  E. Londos,et al.  Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer’s disease , 2011, Journal of Neural Transmission.

[50]  P. Faller,et al.  Copper(II) coordination to amyloid β: murine versus human peptide. , 2011, Angewandte Chemie.

[51]  D. Wales,et al.  Transmembrane structures for Alzheimer's Aβ(1-42) oligomers. , 2010, Journal of the American Chemical Society.

[52]  S. Linse,et al.  Retardation of Abeta fibril formation by phospholipid vesicles depends on membrane phase behavior. , 2010, Biophysical journal.

[53]  Ruth Nussinov,et al.  Truncated β-amyloid peptide channels provide an alternative mechanism for Alzheimer’s Disease and Down syndrome , 2010, Proceedings of the National Academy of Sciences.

[54]  Ian Parker,et al.  Calcium Signaling and Amyloid Toxicity in Alzheimer Disease* , 2010, The Journal of Biological Chemistry.

[55]  P. Faller,et al.  Pulse EPR spectroscopy reveals the coordination sphere of copper(II) ions in the 1-16 amyloid-beta peptide: a key role of the first two N-terminus residues. , 2009, Angewandte Chemie.

[56]  J. H. Viles,et al.  Copper(II) binding to amyloid-beta fibrils of Alzheimer's disease reveals a picomolar affinity: stoichiometry and coordination geometry are independent of Abeta oligomeric form. , 2009, Biochemistry.

[57]  R. Cole,et al.  Covalently bound fluorescent probes as reporters for hydroxyl radical penetration into liposomal membranes. , 2009, Free radical biology & medicine.

[58]  P. Faller,et al.  Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-beta peptide. , 2009, Dalton transactions.

[59]  J. Díaz,et al.  Efficiency of histidine-associating compounds for blocking the alzheimer's Abeta channel activity and cytotoxicity. , 2008, Biophysical journal.

[60]  Michal Afri,et al.  Determining radical penetration of lipid bilayers with new lipophilic spin traps. , 2008, Free radical biology & medicine.

[61]  P. Palumaa,et al.  Binding of zinc(II) and copper(II) to the full‐length Alzheimer’s amyloid‐β peptide , 2008, Journal of neurochemistry.

[62]  J. Danielsson,et al.  Positioning of the Alzheimer Aβ(1–40) peptide in SDS micelles using NMR and paramagnetic probes , 2007, Journal of biomolecular NMR.

[63]  Astrid Gräslund,et al.  High‐resolution NMR studies of the zinc‐binding site of the Alzheimer's amyloid β‐peptide , 2007 .

[64]  Antonio Lanzirotti,et al.  Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease. , 2006, Journal of structural biology.

[65]  C. Masters,et al.  Copper-mediated Amyloid-β Toxicity Is Associated with an Intermolecular Histidine Bridge* , 2006, Journal of Biological Chemistry.

[66]  Hai Lin,et al.  Amyloid ion channels: a common structural link for protein-misfolding disease. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[67]  K. Brogden.  Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? , 2005, Nature Reviews Microbiology.

[68]  Rushana Azimova,et al.  Amyloid Peptide Channels , 2004, The Journal of Membrane Biology.

[69]  A. Watts,et al.  Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation. , 2004, Journal of molecular biology.

[70]  R. Lal,et al.  Amyloid β protein forms ion channels: implications for Alzheimer's disease pathophysiology , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[71]  Y. Kozutsumi,et al.  Cholesterol-dependent Formation of GM1 Ganglioside-bound Amyloid β-Protein, an Endogenous Seed for Alzheimer Amyloid* , 2001, The Journal of Biological Chemistry.

[72]  C. Masters,et al.  Alzheimer's Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits* , 2001, The Journal of Biological Chemistry.

[73]  Hai Lin,et al.  Fresh and nonfibrillar amyloid β protein(1–40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AβP‐channel‐mediated cellular toxicity , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  R. Lal,et al.  Fresh and globular amyloid β protein (1–42) induces rapid cellular degeneration: evidence for AβP channel‐mediated cellular toxicity , 2000 .

[75]  W. Markesbery,et al.  Electrochemical Analysis of Protein Nitrotyrosine and Dityrosine in the Alzheimer Brain Indicates Region-Specific Accumulation , 1998, The Journal of Neuroscience.

[76]  D. Craik,et al.  Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? , 1998, Biochemistry.

[77]  J. D. Robertson,et al.  Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.

[78]  J. Seelig,et al.  Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes. , 1997, Biochemistry.

[79]  M. Kawahara,et al.  Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons. , 1997, Biophysical journal.

[80]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[81]  Maya L. Gosztyla,et al.  Alzheimer's Amyloid-β is an Antimicrobial Peptide: A Review of the Evidence. , 2018, Journal of Alzheimer's disease : JAD.